Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Tetrabenazine
Trade Name: Xenazine
Date Designated: 12/11/1997
Orphan Designation: Treatment of Huntington's disease
Orphan Designation Status: Designated/Approved
Prestwick Pharmaceuticals, Inc
1825 K Street NW
Suite 1475
Washington, District of Columbia 20006
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Tetrabenazine
Trade Name: Xenazine
Marketing Approval Date: 08/15/2008
Approved Labeled Indication: Treatment of chorea associated with Huntington's disease
Exclusivity End Date: 08/15/2015 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-